Schiffer Angélique A, Pedersen Susanne S, Broers Herman, Widdershoven Jos W, Denollet Johan
CoRPS - Center of Research on Psychology in Somatic diseases, Tilburg University, the Netherlands.
J Affect Disord. 2008 Feb;106(1-2):73-81. doi: 10.1016/j.jad.2007.05.021. Epub 2007 Jul 5.
Chronic heart failure (CHF) is a debilitating condition associated with poor outcome, including increased anxiety. However, anxiety and its determinants have not yet been studied systematically in CHF. We examined whether type-D personality and depressive symptoms would predict clinically significant anxiety at 1-year follow-up.
Consecutive patients with systolic CHF (n=149; 79% men; mean age 66+/-8.6) completed the type-D Scale (DS14), the Beck Depression Inventory, and the Anxiety Sensitivity Index at baseline. A clinical interview (Hamilton Anxiety Rating Scale) was used to assess clinically significant anxiety at 1-year follow-up.
At 12 months follow-up, 26% (9/35) of type-D patients had clinically significant anxiety versus only 6% (7/114) of the non type-Ds (p=0.001). In univariable analyses, type-D personality (OR=5.3; p=0.002) and anxiety sensitivity (OR=4.5; p=0.009), but not depressive symptoms (p=0.27) predicted clinically significant anxiety. Type-D remained an independent predictor of anxiety at 1 year (OR=5.7; p=0.01), controlling for depressive symptoms, anxiety sensitivity, socio-demographic and clinical variables. Adding type-D in a hierarchical logistic regression model, comprising standard and psychological risk factors, enhanced the level of prediction of clinically significant anxiety substantially (-2LL=75.16 chi(2)=26.46; p=0.009).
Type-D personality, but not depressive symptoms predicted 1-year clinically significant anxiety. The type-D scale could be used to identify CHF patients at high risk of anxiety, as these patients may be at an increased risk of adverse prognosis and impaired quality of life.
慢性心力衰竭(CHF)是一种使人衰弱的疾病,与不良预后相关,包括焦虑增加。然而,尚未在CHF患者中对焦虑及其决定因素进行系统研究。我们研究了D型人格和抑郁症状是否能预测1年随访时具有临床意义的焦虑。
连续入选的收缩性CHF患者(n = 149;79%为男性;平均年龄66±8.6岁)在基线时完成D型量表(DS14)、贝克抑郁量表和焦虑敏感性指数评估。采用临床访谈(汉密尔顿焦虑评定量表)评估1年随访时具有临床意义的焦虑。
在12个月随访时,26%(9/35)的D型患者有具有临床意义的焦虑,而非D型患者中只有6%(7/114)有(p = 0.001)。在单变量分析中,D型人格(OR = 5.3;p = 0.002)和焦虑敏感性(OR = 4.5;p = 0.009)可预测具有临床意义的焦虑,而抑郁症状则不能(p = 0.27)。在控制抑郁症状、焦虑敏感性、社会人口学和临床变量后,D型人格在1年时仍是焦虑的独立预测因素(OR = 5.7;p = 0.01)。在包含标准和心理风险因素的分层逻辑回归模型中加入D型人格,可显著提高对具有临床意义的焦虑的预测水平(-2LL = 75.16,χ² = 26.46;p = 0.009)。
D型人格而非抑郁症状可预测1年时具有临床意义的焦虑。D型量表可用于识别焦虑风险高的CHF患者,因为这些患者可能预后不良和生活质量受损的风险增加。